Efforts to reduce the spread of human immunodeficiency virus (HIV) and find innovative alternatives to condom use are important public health challenges. While the incidence of HIV is leveling off among some populations, it is escalating in other populations such as young African American men who have sex with men (MSM). Guided by the health belief model (HBM) and the AIDS risk reduction model (ARRM), this quantitative, cross-sectional study sought to use multiple linear regression, binary logistic regression, and Fisher's exact test to determine how perceived susceptibility, as measured by the AIDS Health Belief Scale (AHBS), and labeling of unprotected receptive anal intercourse (URAI) risk predicted the preference for prevention products and the number of self-reported sexual activities among MSM who seek sexual partners on the Internet. This study also sought to determine any ethnic differences in the preference for prevention products among these men. Due to the limited sample size (N = 19), there were no significant relationships between the independent variables (i.e., AHBS Score, URAI Risk, or ethnicity) and dependent variables (i.e., product preference or sexual activity). Moreover, covariates of age and alcohol/drug use were not significant in this study. The implications of positive social change include new insights into designing culturally-sensitive, Internet-based, HIV interventions for hard-to-reach and hidden populations that protect their privacy.

Worldwide, more than half of all HIV-infected individuals are women. Since mucosal surfaces are the primary gateway for HIV entry, maintaining the integrity of the female reproductive tract (FRT) is essential for preventing infection. The FRT employs many immune mechanisms that serve as the first line of defense against HIV transmission. Among these are vaginal fluid secretions rich in antimicrobial peptides, and commensal bacteria that colonize the vagina and prevent infections. We sought to study vaginal fluid as an innate immune component of the FRT in the prevention of HIV infection. Additionally, we investigated the anti-HIV microbicide candidate RC-101 as a possible treatment against pathogenic bacteria that disrupt the healthy microbiota of the FRT and create a suboptimal immune state that increases host susceptibility to viruses, such as HIV. Here we report that vaginal fluid collected from healthy females inhibits HIV infection. Moreover, our studies reveal that vaginal fluid collected from Black and White women exhibit disparate anti-HIV activity, possibly rendering Black women more susceptible to HIV infection. In addition, we show that RC-101, which is active against HIV, can also inhibit pathogenic bacteria that compromise FRT innate immunity, providing a dual mechanism of protection against HIV acquisition. Overall, these findings show that vaginal fluid is an important part of female innate immunity that protects the host from heterosexual HIV acquisition. Furthermore, the microbicide RC-101 may prevent HIV infection by both directly preventing viral entry, and by restricting the growth of pathogenic bacteria that disrupt the protective commensal vaginal flora. Together, innate mechanisms and bolstered protection present a multifaceted approach to maintaining effective host immunity.

Mon travail de thèse porte sur l'identification d'un arbre médicinal africain par le DNA barcoding et l'étude de composés à activité anti-VIH de cet arbre. Une première analyse de la séquence du marqueur ITS2 déterminée à partir d'ADN extrait de copeaux de bois a suggéré que la plante pourrait appartenir au genre Cassia ou au genre apparenté Senna. En analysant la séquence de ce marqueur ITS2 et aussi celle du trnHpsbA spacer d'une cinquantaine d'espèces des genres Cassia et Senna j'ai pu identifier la plante comme étant Cassia abbreviata. L'alignement de ces séquences m'a permis d'identifier, pour les deux marqueurs,des structures particulières spécifiques aux espèces du genre Cassia, permettant donc de les différencier des espèces du genre Senna. J'ai utilisé ces alignements pour effectuer une étude phylogenetique qui illustre que,pour les deux marqueurs, les Cassia forment en effet un clade bien séparé du clade des Senna qui peut être divisé en plusieurs sous-clades. Dans un deuxième temps j'ai étudié les effets anti-VIH de l'extrait alcoolique ainsi que de 57 composés purifiés obtenus au laboratoire. L'extrait brut ainsi qu'un des composés purifiés, le piceatannol, ont montré un grand spectre d’activités antivirales pour le VIH et le virus de l’herpès. Ils inhibent,à un stade précoce, l'infection par le VIH de lignées cellulaires de référence et d'isolats cliniques, ceci indépendamment de l'utilisation du co-récepteur (IC50: 10.47-40.77 μg/ml, CC50>1000 μg/ml; IC50: 8.04-47.46 μM, CC50>300 μM, respectivement). Ni l'un ni l'autre n'a d'effet sur CD4 et CCR5/CXCR4. L'extrait brut,mais pas le piceatannol, bloque l'interaction CD4-gp120, suggérant que l'extrait brut cible gp120 alors que le piceatannol agit comme un inhibiteur non-spécifique d'attachement du virus. Aussi, dans un modèle in vitro de tract génital femelle, le piceatannol inhibe l'infection de cellules cibles TZM-Bl par le VIH et n'active pas les cellules PBMCs, suggérant qu'il pourrait être un bon candidat comme microbicide. D'autres composés à activité anti-VIH dans l'extrait comportent l'acide oléanolique, l'acide palmitique, la taxifoline, ainsi que troiscomposés dont la structure est en train d'être élucidée. / My thesis project deals with the identification, by DNA barcoding, of an African medicinal plant and the study of anti-HIV compounds from this plant. A first analysis of the ITS2 marker sequence determined from DNA extracted from the wood suggested that the plant could belong to the Cassia or the related Senna genus. A further analysis of ITS2 as well as of trnH-psbA spacer sequences from about 50 species of the two genera allowed me to identify the plant as Cassia abbreviata. The sequence alignments, which reveal unique features present in the Cassia but not the Senna sequences, were used to construct phylogenetic trees showing the clear separation of the species of the Cassia and the Senna genus. The two markers therefore allow a quick discrimination between the species of the Cassia and the Senna genus and appear to be excellent barcode markers for identification of these species. Following the identification of the plant I have tested the crude ethanol extract as well as 57 purified compounds from the plant for an anti-HIV activity. The extract, as well as one of the compounds, namely piceatannol, showed a broad spectrum of antiviral activities for HIV and HSV. They inhibited HIV-1 infection at the early stage against various reference strains and resistant clinical isolates independent of the co-receptor usage (IC50: 10.47-40.77 μg/ml, CC50>1000 μg/ml; IC50: 8.04-47.46 μM,CC50>300 μM, respectively). Neither the crude extract nor piceatannol had an effect on CD4 and CCR5/CXCR4. The crude extract blocked CD4-gp120 interaction while piceatannol did not, indicating that CE may target gp120 and piceatannol may act as a non-specific viral attachment inhibitor. Moreover, piceatannol inhibited HIV infection of TZM-Bl target cells in an in vitro female genital tract model and did not activate PBMCs, suggesting that it may represent a good candidate as microbicide. Other anti-HIV compounds found in Cassia abbreviata include oleanolic acid, palmitic acid, taxifolin and three other compounds the structure of which is presently being elucidated.

Made available in DSpace on 2014-12-17T14:03:37Z (GMT). No. of bitstreams: 1 TicianaMLA_TESE.pdf: 1476361 bytes, checksum: 7074b01e6eb22db7b4cacc005194c334 (MD5) Previous issue date: 2014-04-29 / Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior / Proteinases are enzymes distributed widely founded in several organisms and perform many different functions, from maintaining homeostasis to the worsening of some diseases such as cancer, autoimmune diseases and infections. The proteins responsible of controlling the action of these enzymes are the inhibitors, that are classified based on their target proteases and are founded since simple organisms, such as bacteria, to higher organisms, such as larger plants and mammals. Plant proteinase inhibitors act by reducing or inactivating the activity of target proteases, thus, these proteins have been studied as potential tools in the treatment of diseases related to protease activities. In this context, an inhibitor of chymotrypsin from Erythrina velutina, called EvCI was previously purified and it was observed that this protein plays in vitro anticoagulant activity and anti-inflammatory activity in in vivo model. Aiming to reduce the environmental impact caused by the purification EvCI in high amounts and to facilitate the process of obtaining this protein, the recombinant chymotrypsin inhibitor from Eryhrina velutina was produced after cloning and expression in Escherichia coli. The bacteria were grown in LB medium and after induction of the expression this material was subjected to procedures for cell lysis and the product was applied on Nickel-affinity column. The proteins adsorbed were digested by thrombin and applied on Chymotrypsin-Sepharose affinity column, obtaining the purified inhibitor, named recEvCI. After electrophoresis, the recombinant inhibitor showed an approximately molecular mass of 17 kDa, and reduced the chymotrypsin and elastase activities in vitro. The recombinant inhibitor was sequenced and was found similar amino acids residues when compared to other inhibitors deposited in the database, with some modifications. recEvCI showed high stability under pH variations and reducing conditions, maintaining its activity around 80%. This protein increased the blood coagulation time in vitro by acting on the intrinsic pathway and did not show cytotoxicity against strains of mouse 3T3 fibroblasts and RAW 264.7 macrophages. recEvCI showed microbicide activity related to release of nitric oxide and consequently the activation of macrophages, futhermore having proinflammatory effects assessed by increased release of TNF-α. These results indicate that recEvCI can be biotechnologically used as a new tool in the control of coagulation-related diseases as well as can be an activating agent of the immune system in immunosuppressed individuals / Proteinases s?o enzimas amplamente distribu?das em diferentes organismos e que desempenham as mais diversas fun??es, desde a manuten??o da homeostase at? o agravamento de algumas doen?as como c?ncer, doen?as autoimunes e infec??es. As prote?nas respons?veis pelo controle e atua??o destas enzimas s?o os inibidores, que s?o classificados de acordo com suas proteases alvo e s?o encontrados desde organismos mais simples, como bact?rias, aos mais complexos, como plantas de grande porte e mam?feros. Inibidores de proteinases de plantas agem reduzindo ou inativando a atividade de enzimas alvo, dessa forma, estas prote?nas v?m sendo estudadas como poss?veis ferramentas no tratamento de doen?as relacionadas ?s atividades prote?sicas. Neste contexto, um inibidor de quimotripsina de Erythrina velutina, denominado EvCI, foi previamente purificado e foi observado que esta prote?na desempenha atividades anticoagulante in vitro a anti-inflamat?ria em modelo in vivo. Buscando reduzir o impacto ecol?gico causado pela purifica??o de EvCI em grandes quantidades e facilitar o processo de obten??o desta prote?na, o inibidor de quimotripsina recombinante de Erythrina velutina foi produzido ap?s clonagem e express?o em c?lulas de Escherichia coli. As bact?rias foram crescidas em meio LB e ap?s indu??o da express?o este material foi submetido a procedimentos de lise celular e o produto foi aplicado em uma coluna de afinidade de N?quel. As prote?nas ligadas ? coluna foram digeridas por trombina, aplicadas em uma coluna de afinidade de Quimotripsina-Sepharose obtendo-se o inibidor purificado, denominado recEvCI. Ap?s eletroforese, o inibidor recombinante apresentou uma massa molecular de, aproximadamente, 17 kDA e reduziu a atividade de quimotripsina e elastase in vitro. O inibidor recombinante foi sequenciado e foi detectada a presen?a de amino?cidos iguais a outros inibidores depositados em banco de dados, com algumas modifica??es. recEvCI demonstrou alta estabilidade quando submetido a varia??es de pH e sob condi??es redutoras, mantendo sua atividade inibit?ria em torno de 80%. Esta prote?na aumentou o tempo de coagula??o sangu?nea in vitro por atua??o sobre a via intr?nseca e n?o demostrou citotoxicidade contra as linhagens de fibroblasto de camundongo 3T3 e de macr?fagos RAW 264.7. recEvCI apresentou atividade microbicida relacionada ? libera??o de ?xido n?trico e consequente ativa??o de macr?fagos, al?m de possuir efeito pr?-inflamat?rio avaliado pelo aumento da libera??o de TNF-α. Estes resultados indicam que recEvCI pode ser utilizado biotecnologicamente como uma nova ferramenta no controle de doen?as relacionadas ? coagula??o assim como pode vir a ser um agente ativador do sistema imune em indiv?duos imunossuprimidos

Estudos têm mostrado a incidência de mastite bovina associada à alga Prototheca zopfii. O objetivo deste trabalho foi estudar a interação da P. zopfii com neutrófilos recuperados de leite bovino e avaliar o efeito do sistema ácido indol-3-acético/peroxidase de raiz forte (AIA/HRP) sobre a viabilidade deste microrganismo em experimentos in vitro. A P. zopfii foi recuperada de vacas com mastite clínica e, no laboratório, foram realizadas a caracterização molecular, morfológica e crescimento exponencial do microrganismo. Em seguida, neutrófilos recuperados de leite bovino foram incubados na ausência e na presença de P. zopfii opsonizada e foram avaliadas a produção de peróxido de hidrogênio, enzimas antioxidantes dos neutrófilos e microrganismo, e a capacidade fagocitária. Em outro estudo, a P. zopfii foi incubada com o sistema AIA/HRP e foram avaliadas a viabilidade por unidades formadoras de colônias (UFC), atividade de enzimas antioxidantes, integridade de membrana por exclusão com azul de Trypan e integridade do DNA. Os resultados foram analisados pela análise de variância com significância de 5% usando o teste Tukey. Foram observados diversos tamanhos celulares da P. zopfii, presença de autofluorescência, crescimento exponencial ao longo do tempo de incubação em que não foi possível determinar o início da fase de morte. Ainda, foram encontrados os genótipos 1, 2 e 3 nos isolados em estudo. A produção de peróxido de hidrogênio pelos neutrófilos na presença da alga foi estimulada 5 vezes em relação ao controle, estimulou a atividade das enzimas catalase (CAT) em 21% e glutationa redutase (GR) em 27% e não houve diferença significativa quanto à atividade de CAT, GR e superóxido dismutase (SOD) produzido pela P. zopfii. Também foi verificado que a P. zopfii não foi englobada pelo neutrófilo. O sistema AIA/HRP inibiu o crescimento do microrganismo em 45, 82 e 88% nos tempos de 4, 6 e 9 horas de incubação; a atividade da SOD, CAT, Glutationa Peroxidase (GPx) e GR aumentou respectivamente em 90, 120, 150% e 3,4 vezes; houve redução da viabilidade da P. zopfii em 10, 15, 20, 25 e 32% após os tempos de 4, 6, 8, 10 e 12 horas de incubação; e não afetou a integridade do DNA após 6 horas de incubação. Conclui-se que a P. zopfii é altamente resistente frente aos neutrófilos e demonstrou ser susceptível quanto ao efeito microbicida do sistema AIA/HRP. / Studies have shown the incidence of bovine mastitis associated with the algae Prototheca zopfii. The objective of this work was to study the interaction of P. zopfii with neutrophils recovered from bovine milk and to evaluate the effect of system indole-3-acetic acid/horseradish peroxidase (IAA/HRP) on the viability of this microorganism in vitro experiment. P. zopfii was recovered from cows with clinical mastitis and both the molecular and morphological characterization were performed besides the evaluation of exponential growth of the microorganism in the laboratory. Next, neutrophils recovered from bovine milk were incubated in the absence and presence of opsonized P. zopfii and were evaluated the production of hydrogen peroxide, antioxidant enzymes on neutrophils and microorganism, and phagocytic capacity. In another study, P. zopfii was incubated with the system IAA/HRP and the viability assessed by colony forming units (CFU), antioxidant enzymes activity, membrane integrity by exclusion with Trypan blue and DNA integrity. The results were analyzed by analysis of variance with a 5% significance using the Tukey test. Results from P. zopfii characterization showed various cellular sizes, presence of autofluorescence, exponential microorganism growth throughout the incubation time and was not possible to determine the beginning of the death. Moreover it was found genotypes 1, 2 and 3 in the isolates in study. The production of hydrogen peroxide by neutrophils in the presence of algae was stimulated 5 times compared to the control, increase the activity of catalase (CAT) in 21% and glutathione reductase (GR) in 27% was seen in neutrophils; and there was no significant difference in CAT, GR and superoxide dismutase (SOD) activity produced by P. zopfii. P. zopfii was not engulfment by neutrophils. The system IAA/HRP inhibited the growth of the microorganism in 45, 82 and 88% in the times of 4, 6 and 9 hours of incubation, the activity of SOD, CAT, glutathione peroxidase (GPx) and GR increased respectively by 90, 120, 150%, and 3.4 times, decreased the viability of P. zopfii 10, 15, 20, 25 and 32% after the times of 4, 6, 8, 10 and 12 hours of incubation, and did not affect the integrity of DNA after 6 hours of incubation. As a conclusion, P. zopfii is highly resistant to the neutrophils and demonstrated to be susceptible to the effect microbicidal of system IAA/HRP.

Estudos têm mostrado a incidência de mastite bovina associada à alga Prototheca zopfii. O objetivo deste trabalho foi estudar a interação da P. zopfii com neutrófilos recuperados de leite bovino e avaliar o efeito do sistema ácido indol-3-acético/peroxidase de raiz forte (AIA/HRP) sobre a viabilidade deste microrganismo em experimentos in vitro. A P. zopfii foi recuperada de vacas com mastite clínica e, no laboratório, foram realizadas a caracterização molecular, morfológica e crescimento exponencial do microrganismo. Em seguida, neutrófilos recuperados de leite bovino foram incubados na ausência e na presença de P. zopfii opsonizada e foram avaliadas a produção de peróxido de hidrogênio, enzimas antioxidantes dos neutrófilos e microrganismo, e a capacidade fagocitária. Em outro estudo, a P. zopfii foi incubada com o sistema AIA/HRP e foram avaliadas a viabilidade por unidades formadoras de colônias (UFC), atividade de enzimas antioxidantes, integridade de membrana por exclusão com azul de Trypan e integridade do DNA. Os resultados foram analisados pela análise de variância com significância de 5% usando o teste Tukey. Foram observados diversos tamanhos celulares da P. zopfii, presença de autofluorescência, crescimento exponencial ao longo do tempo de incubação em que não foi possível determinar o início da fase de morte. Ainda, foram encontrados os genótipos 1, 2 e 3 nos isolados em estudo. A produção de peróxido de hidrogênio pelos neutrófilos na presença da alga foi estimulada 5 vezes em relação ao controle, estimulou a atividade das enzimas catalase (CAT) em 21% e glutationa redutase (GR) em 27% e não houve diferença significativa quanto à atividade de CAT, GR e superóxido dismutase (SOD) produzido pela P. zopfii. Também foi verificado que a P. zopfii não foi englobada pelo neutrófilo. O sistema AIA/HRP inibiu o crescimento do microrganismo em 45, 82 e 88% nos tempos de 4, 6 e 9 horas de incubação; a atividade da SOD, CAT, Glutationa Peroxidase (GPx) e GR aumentou respectivamente em 90, 120, 150% e 3,4 vezes; houve redução da viabilidade da P. zopfii em 10, 15, 20, 25 e 32% após os tempos de 4, 6, 8, 10 e 12 horas de incubação; e não afetou a integridade do DNA após 6 horas de incubação. Conclui-se que a P. zopfii é altamente resistente frente aos neutrófilos e demonstrou ser susceptível quanto ao efeito microbicida do sistema AIA/HRP. / Studies have shown the incidence of bovine mastitis associated with the algae Prototheca zopfii. The objective of this work was to study the interaction of P. zopfii with neutrophils recovered from bovine milk and to evaluate the effect of system indole-3-acetic acid/horseradish peroxidase (IAA/HRP) on the viability of this microorganism in vitro experiment. P. zopfii was recovered from cows with clinical mastitis and both the molecular and morphological characterization were performed besides the evaluation of exponential growth of the microorganism in the laboratory. Next, neutrophils recovered from bovine milk were incubated in the absence and presence of opsonized P. zopfii and were evaluated the production of hydrogen peroxide, antioxidant enzymes on neutrophils and microorganism, and phagocytic capacity. In another study, P. zopfii was incubated with the system IAA/HRP and the viability assessed by colony forming units (CFU), antioxidant enzymes activity, membrane integrity by exclusion with Trypan blue and DNA integrity. The results were analyzed by analysis of variance with a 5% significance using the Tukey test. Results from P. zopfii characterization showed various cellular sizes, presence of autofluorescence, exponential microorganism growth throughout the incubation time and was not possible to determine the beginning of the death. Moreover it was found genotypes 1, 2 and 3 in the isolates in study. The production of hydrogen peroxide by neutrophils in the presence of algae was stimulated 5 times compared to the control, increase the activity of catalase (CAT) in 21% and glutathione reductase (GR) in 27% was seen in neutrophils; and there was no significant difference in CAT, GR and superoxide dismutase (SOD) activity produced by P. zopfii. P. zopfii was not engulfment by neutrophils. The system IAA/HRP inhibited the growth of the microorganism in 45, 82 and 88% in the times of 4, 6 and 9 hours of incubation, the activity of SOD, CAT, glutathione peroxidase (GPx) and GR increased respectively by 90, 120, 150%, and 3.4 times, decreased the viability of P. zopfii 10, 15, 20, 25 and 32% after the times of 4, 6, 8, 10 and 12 hours of incubation, and did not affect the integrity of DNA after 6 hours of incubation. As a conclusion, P. zopfii is highly resistant to the neutrophils and demonstrated to be susceptible to the effect microbicidal of system IAA/HRP.

No description available.

No description available.

The HIV-1 pandemic affects millions of people worldwide with approximately 70% of those affected residing in sub-Saharan Africa (SSA) relying on traditional medicines for treatment. The key aim of the study was to isolate and characterise an active phyto-pharmaceutical ingredient (API) from L. trigonus for use as a vaginal microbicide. The aerial parts of L. trigonus were oven-dried at 80°C, ground and then extracted with boiling water for 30 minutes. Aqueous extracts were screened using an HIV-1 neutralization assay in TZM bl cells. Chromatographic and spectroscopic techniques were used to purify, isolate and identify the API. The API (BP36-117-26464C) was identified as a polymeric macromolecule with IC50 = 0.04 μg/ml against HIV-1 HXB 2 subtype B. This activity is comparable to the ARV drug, enfuvirtide (IC50 = 0.02 μg/ml). The API consists of galacturonic acid polymer and a mixture of seven compounds. Its mode of action may involve inhibiting virus attachment. The activity of this precipitate (BP36-117-26464C) tested against HIV-1 subtype C pseudovirions and shown to compare favorably with that of enfuvirtide (T20). The water-soluble nature of this API and its mode of action identified it as a potential microbicide. In the current form, the precipitate (API) would be difficult to develop as an oral treatment for HIV, as high-molecular weight agents often have poor bioavailability following oral administration. However, large molecules with potent anti-HIV activity are ideal for topical use and potent development as a microbicide. / Life & Consumer Sciences / M.Sc (Life Sciences)

The HIV-1 pandemic affects millions of people worldwide with approximately 70% of those affected residing in sub-Saharan Africa (SSA) relying on traditional medicines for treatment. The key aim of the study was to isolate and characterise an active phyto-pharmaceutical ingredient (API) from L. trigonus for use as a vaginal microbicide. The aerial parts of L. trigonus were oven-dried at 80°C, ground and then extracted with boiling water for 30 minutes. Aqueous extracts were screened using an HIV-1 neutralization assay in TZM bl cells. Chromatographic and spectroscopic techniques were used to purify, isolate and identify the API. The API (BP36-117-26464C) was identified as a polymeric macromolecule with IC50 = 0.04 μg/ml against HIV-1 HXB 2 subtype B. This activity is comparable to the ARV drug, enfuvirtide (IC50 = 0.02 μg/ml). The API consists of galacturonic acid polymer and a mixture of seven compounds. Its mode of action may involve inhibiting virus attachment. The activity of this precipitate (BP36-117-26464C) tested against HIV-1 subtype C pseudovirions and shown to compare favorably with that of enfuvirtide (T20). The water-soluble nature of this API and its mode of action identified it as a potential microbicide. In the current form, the precipitate (API) would be difficult to develop as an oral treatment for HIV, as high-molecular weight agents often have poor bioavailability following oral administration. However, large molecules with potent anti-HIV activity are ideal for topical use and potent development as a microbicide. / Life and Consumer Sciences / M.Sc (Life Sciences)